Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
Clinical trial NCT00509145 · COMPLETED
Trial details
- NCT number
- NCT00509145
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-13
- Primary completion
- 2010-11-08
- Enrollment
- 1106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.